Condition: Aortic Dissection · Aortic Aneurysm · Intramural Hematoma · Sponsor: Endospan Ltd.
Prospective, non-randomized, multi-center clinical investigation of the NEXUS™ Aortic Arch Stent Graft System (NEXUSTM) for the treatment of thoracic aortic lesions involving the aortic arch with a proximal landing zone, native or previously implanted surgical graft, in the ascending aorta and with a brachiocephalic trunk native landing zone.
This description comes directly from the study's public registry record.
Jessica Kleine · +1 (612) 280-0208 · j.kleine@endospan.com
Always discuss trial participation with your own doctor first.
| University of Alabama Birmingham | Birmingham, Alabama, United States | Recruiting |
| University of California San Diego Medical Center | La Jolla, California, United States | Recruiting |
| UC Davis Health | Sacramento, California, United States | Completed |
| Stanford University School of Medicine | Stanford, California, United States | Recruiting |
| University of Colorado | Aurora, Colorado, United States | Recruiting |
| Hartford Hospital | Hartford, Connecticut, United States | Recruiting |
| MedStar Washington Hospital | Washington D.C., District of Columbia, United States | Recruiting |
| Advent Health Orlando | Orlando, Florida, United States | Completed |
| Emory University | Atlanta, Georgia, United States | Recruiting |
| The University of Chicago | Chicago, Illinois, United States | Recruiting |
| Ascension St. Vincent | Carmel, Indiana, United States | Completed |
| University of Maryland | Baltimore, Maryland, United States | Recruiting |
+ 20 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04471909